跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 100 条关于
“Galanthus nivalis agglutinin”
全部
100
临床试验
60
药物
11
机构
2
资讯
27
2个月前
Aethlon Medical Identifies Novel Long COVID Biomarker, Strengthening Rationale for Hemopurifier® Platform
去年
Aethlon Medical's Hemopurifier Shows Promise for Long COVID Treatment Through Extracellular Vesicle Removal
去年
Aethlon Medical's Hemopurifier Shows Potential in Capturing H5N1 Bird Flu In Vitro
9个月前
Aethlon Medical's Hemopurifier Shows Promise for Long COVID Treatment in Preclinical Study
9个月前
Real-World Safety Data Confirms Long-Term Tolerability of ENJAYMO in Cold Agglutinin Disease Patients
去年
Low-Dose Rituximab Trial Shows Limited Efficacy in Cold Agglutinin Disease Patients
去年
Aethlon Medical Advances Hemopurifier Cancer Trial with First Three Patients Treated and Indian Regulatory Approval
10个月前
Recordati Rare Diseases Presents Nine Research Studies on Rare Hematologic Disorders at ASH 2025
去年
Annexon Advances Neuroinflammatory Pipeline: ANX005, ANX007, and ANX1502 Lead the Charge
去年
FDA Approves Sanofi's Enjaymo: First Targeted Therapy for Rare Blood Disorder CAD
第 1 页,共 3 页
上一页
下一页